iBio Inc (NASDAQ:IBIO) has a beta value of 1.55 and has seen 9.14 million shares traded in the last trading session. The company, currently valued at $6.91M, closed the last trade at $0.70 per share which meant it lost -$0.15 on the day or -17.43% during that session. The IBIO stock price is -884.29% off its 52-week high price of $6.89 and -20.0% below the 52-week low of $0.84. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.51 million shares traded. The 3-month trading volume is 638.13K shares.
The consensus among analysts is that iBio Inc (IBIO) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.32.
iBio Inc (NASDAQ:IBIO) trade information
Sporting -17.43% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the IBIO stock price touched $0.70 or saw a rise of 41.06%. Year-to-date, iBio Inc shares have moved -71.43%, while the 5-day performance has seen it change -40.68%. Over the past 30 days, the shares of iBio Inc (NASDAQ:IBIO) have changed -84.88%. Short interest in the company has seen 1.17 million shares shorted with days to cover at 1.81.
Wall Street analysts have a consensus price target for the stock at $3.6, which means that the shares’ value could jump 80.56% from current levels. The projected low price target is $3.6 while the price target rests at a high of $3.6. In that case, then, we find that the current price level is -414.29% off the targeted high while a plunge would see the stock gain -414.29% from current levels.
iBio Inc (IBIO) estimates and forecasts
The company’s shares have lost -75.44% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 77.78%.
2 analysts offering their estimates for the company have set an average revenue estimate of 100k for the current quarter. 2 have an estimated revenue figure of 100k for the next ending quarter.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 57.55% over the past 5 years. Earnings growth for 2025 is a modest 60.55% while over the next 5 years, the company’s earnings are expected to increase by 45.01%.
IBIO Dividends
iBio Inc is expected to release its next earnings report on 2025-Feb-09 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
iBio Inc (NASDAQ:IBIO)’s Major holders
Insiders own 7.21% of the company shares, while shares held by institutions stand at 26.65% with a share float percentage of 28.72%. Investors are also buoyed by the number of investors in a company, with iBio Inc having a total of 34.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.74% shares in the company for having 73.14 shares of worth $51201.0 while later fund manager owns 45.79 shares of worth $32054.0 as of Feb 28, 2025 , which makes it owner of about 0.46% of company’s outstanding stock.
